Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

621
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
621
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

53
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

34
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Narrowing to Vulnerability: Rethinking Carotid Revascularization in the Era of Advanced Imaging.

European journal of preventive cardiology·2026
Same author

Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three-Dimensional Vascular Ultrasound.

Diabetes, obesity & metabolism·2026
Same author

Brainstem vascular syndromes.

Handbook of clinical neurology·2026
Same author

Alphonse Daudet's Description of Jean-Martin Charcot: A Perception That Blends Medicine, Literature, and Society.

Neurology·2026
Same author

Honoré de Balzac's Story of Vanda de Mergi: The First Modern Case of Neurologic Functional Disorder?

Neurology·2026
Same author

The prevalence of carotid subclinical atherosclerosis according to age: A systematic review and meta-analysis of the young to middle-age.

Journal of clinical lipidology·2025

Related Experiment Video

Updated: May 5, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

13.3K

High-dose atorvastatin after stroke or transient ischemic attack.

Pierre Amarenco1, Julien Bogousslavsky, Alfred Callahan

  • 1Denis Diderot University, Paris.

The New England Journal of Medicine
|August 11, 2006
PubMed
Summary

Atorvastatin significantly reduced stroke incidence in patients with recent stroke or TIA. This statin therapy lowered cardiovascular event risk without increasing overall mortality.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.4K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

14.4K

Related Experiment Videos

Last Updated: May 5, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

13.3K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.4K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

14.4K

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Statins are known to reduce cardiovascular disease risk.
  • The efficacy of statins in preventing recurrent strokes after a recent stroke or transient ischemic attack (TIA) was previously unestablished.

Purpose of the Study:

  • To investigate the effectiveness of atorvastatin in reducing stroke incidence in patients who recently experienced a stroke or TIA.

Main Methods:

  • A double-blind, placebo-controlled trial involving 4731 patients with recent stroke/TIA and LDL cholesterol between 100-190 mg/dL.
  • Patients received either 80 mg of atorvastatin daily or a placebo for a median follow-up of 4.9 years.

Main Results:

  • Atorvastatin reduced the risk of fatal or nonfatal stroke by 11.2% compared to 13.1% in the placebo group (absolute risk reduction 2.2%).
  • The incidence of major cardiovascular events was also reduced by 3.5% in the atorvastatin group.
  • While ischemic strokes decreased, there was a slight increase in hemorrhagic strokes; however, overall mortality and serious adverse events were similar between groups.

Conclusions:

  • Daily 80 mg atorvastatin effectively reduces the overall incidence of strokes and cardiovascular events in patients with recent stroke or TIA.
  • The benefits of atorvastatin in this patient population outweigh the risks, including a small increase in hemorrhagic stroke incidence.